High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders

被引：20

作者：

Bowcock, Stella J. ^{[1
]}

Rassam, Saad M. B.

Lim, Ziyi

Ward, Susan M.

Ryali, Madan M.

Mufti, Ghulam J.

机构：

[1] Queen Marys Sidcup NHS Trust, Dept Haematol, Sidcup, Kent, England

[2] Maidstone Hlth Author, Dept Haematol, Maidstone, Kent, England

[3] Kings Coll London, Sch Med, London WC2R 2LS, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2006年 / 134卷 / 02期

关键词：

myelodysplasia; acute leukaemia; fludarabine; elderly; therapy related; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; LYMPHOMA;

D O I：

10.1111/j.1365-2141.2006.06158.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：242 / 243

页数：2

共 6 条

[1] Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab [J].

Bennett, JM ;

Kaminski, MS ;

Leonard, JP ;

Vose, JM ;

Zelenetz, AD ;

Knox, SJ ;

Horning, S ;

Press, OW ;

Radford, JA ;

Kroll, SM ;

Capizzi, RL .

BLOOD, 2005, 105 (12) :4576-4582

[2] Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha [J].

McLaughlin, P ;

Estey, E ;

Glassman, A ;

Romaguera, J ;

Samaniego, F ;

Ayala, A ;

Hayes, K ;

Maddox, AM ;

Preti, HA ;

Hagemeister, FB .

BLOOD, 2005, 105 (12) :4573-4575

[3] High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia [J].

Milligan, DW ;

Kochethu, G ;

Dearden, C ;

Matutes, E ;

MacConkey, C ;

Catovsky, D .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (02) :173-175

Morrison, VA ;

Rai, KR ;

Peterson, BL ;

Kolitz, JE ;

Elias, L ;

Appelbaum, FR ;

Hines, JD ;

Shepherd, L ;

Larson, RA ;

Schiffer, CA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3878-3884

[5] RISK OF THERAPY-RELATED LEUKEMIA AND PRELEUKEMIA AFTER HODGKINS-DISEASE - RELATION TO AGE, CUMULATIVE DOSE OF ALKYLATING-AGENTS, AND TIME FROM CHEMOTHERAPY [J].

PEDERSENBJERGAARD, J ;

LARSEN, SO ;

STRUCK, J ;

HANSEN, HH ;

SPECHT, L ;

ERSBOLL, J ;

HANSEN, MM ;

NISSEN, NI .

LANCET, 1987, 2 (8550) :83-88

[6]

PEDERSONBJERGAA.J, 2001, ASCO ED BOOK SPR, P566

← 1 →